| Plasma AR and abiraterone-resistant prostate cancer A Romanel, DG Tandefelt, V Conteduca, A Jayaram, N Casiraghi, ... Science translational medicine 7 (312), 312re10-312re10, 2015 | 452 | 2015 |
| PTEN deficiency in endometrioid endometrial adenocarcinomas predicts sensitivity to PARP inhibitors KJ Dedes, D Wetterskog, AM Mendes-Pereira, R Natrajan, MB Lambros, ... Science translational medicine 2 (53), 53ra75-53ra75, 2010 | 405 | 2010 |
| Emerging therapeutic targets in endometrial cancer KJ Dedes, D Wetterskog, A Ashworth, SB Kaye, JS Reis-Filho Nature reviews Clinical oncology 8 (5), 261-271, 2011 | 330 | 2011 |
| Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution … V Conteduca, D Wetterskog, MTA Sharabiani, E Grande, ... Annals of Oncology 28 (7), 1508-1516, 2017 | 265 | 2017 |
| Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations KJ Dedes, PM Wilkerson, D Wetterskog, B Weigelt, A Ashworth, ... Cell cycle 10 (8), 1192-1199, 2011 | 224 | 2011 |
| Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple‐negative and basal‐like breast cancers D Wetterskog, MA Lopez‐Garcia, MB Lambros, R A'Hern, FC Geyer, ... The Journal of pathology 226 (1), 84-96, 2012 | 183 | 2012 |
| Functional viability profiles of breast cancer R Brough, JR Frankum, D Sims, A Mackay, AM Mendes-Pereira, I Bajrami, ... Cancer discovery 1 (3), 260-273, 2011 | 171 | 2011 |
| Genome-wide plasma DNA methylation features of metastatic prostate cancer A Wu, P Cremaschi, D Wetterskog, V Conteduca, GM Franceschini, ... The Journal of clinical investigation 130 (4), 1991-2000, 2020 | 78 | 2020 |
| Plasma androgen receptor and docetaxel for metastatic castration-resistant prostate cancer V Conteduca, A Jayaram, N Romero-Laorden, D Wetterskog, S Salvi, ... European urology 75 (3), 368-373, 2019 | 78 | 2019 |
| Functional characterization of the 19q12 amplicon in grade III breast cancers R Natrajan, A Mackay, PM Wilkerson, MB Lambros, D Wetterskog, ... Breast Cancer Research 14, 1-15, 2012 | 76 | 2012 |
| Loss of Redness (a*) as a Tool To Follow Hemoglobin-Mediated Lipid Oxidation in Washed Cod Mince D Wetterskog, I Undeland Journal of agricultural and food chemistry 52 (24), 7214-7221, 2004 | 69 | 2004 |
| Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse S Taavitsainen, N Engedal, S Cao, F Handle, A Erickson, S Prekovic, ... Nature communications 12 (1), 5307, 2021 | 68 | 2021 |
| Identification of novel determinants of resistance to lapatinib in ERBB2-amplified cancers D Wetterskog, KK Shiu, I Chong, T Meijer, A Mackay, M Lambros, ... Oncogene 33 (8), 966-976, 2014 | 59 | 2014 |
| Circulating tumor DNA in advanced prostate cancer: transitioning from discovery to a clinically implemented test E Gonzalez-Billalabeitia, V Conteduca, D Wetterskog, A Jayaram, ... Prostate cancer and prostatic diseases 22 (2), 195-205, 2019 | 55 | 2019 |
| Mutation profiling of adenoid cystic carcinomas from multiple anatomical sites identifies mutations in the RAS pathway, but no KIT mutations D Wetterskog, PM Wilkerson, DN Rodrigues, MB Lambros, K Fritchie, ... Histopathology 62 (4), 543-550, 2013 | 45 | 2013 |
| Functional characterization of EMSY gene amplification in human cancers PM Wilkerson, KJ Dedes, D Wetterskog, A Mackay, MB Lambros, ... The Journal of Pathology 225 (1), 29-42, 2011 | 45 | 2011 |
| Plasma androgen receptor copy number status at emergence of metastatic castration-resistant prostate cancer: a pooled multicohort analysis A Jayaram, A Wingate, D Wetterskog, V Conteduca, D Khalaf, ... JCO precision oncology 3, 1-13, 2019 | 38 | 2019 |
| Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical study KJ Dedes, MA Lopez-Garcia, FC Geyer, MBK Lambros, K Savage, ... Breast cancer research and treatment 124, 653-666, 2010 | 36 | 2010 |
| LOXL2 induces aberrant acinar morphogenesis via ErbB2 signaling J Chang, MM Nicolau, TR Cox, D Wetterskog, JWM Martens, H E Barker, ... Breast Cancer Research 15, 1-18, 2013 | 35 | 2013 |
| Plasma AR status and cabazitaxel in heavily treated metastatic castration-resistant prostate cancer V Conteduca, E Castro, D Wetterskog, E Scarpi, A Jayaram, ... European Journal of Cancer 116, 158-168, 2019 | 34 | 2019 |
